GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, MET, PPARA, TRPV1 |
8.33112 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.12374 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, KDR, MET, PPARA, SRC, TRPV1, XDH |
6.97353 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.32947 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.08007 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FUT7, PIM1, PPARA, XDH |
5.99933 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.99933 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, F3, FABP3, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
5.86745 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, F3, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
5.86745 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
5.62428 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, HCAR2, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
5.61444 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, HCAR2, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
5.60367 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
5.5994 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC, TRPV1, XDH |
5.42462 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PPARA, PTPN1, SRC, TRPV1 |
5.13598 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, CDC25B, CHRM1, CSNK2A1, CYP1B1, F3, FABP3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
4.96101 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1 |
4.93141 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MET, PPARA |
4.9114 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, HCAR2, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, TRPV1, XDH |
4.75039 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC |
4.73568 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1 |
4.73179 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, PPARA, SRC, TRPV1 |
4.44338 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.34588 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AXL, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, F3, FABP4, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, TRPV1 |
4.33076 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.31718 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP3, IGF1R, MMP2, MMP9, NR3C1, PPARA, SRC, TRPV1 |
4.25084 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
4.23711 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
4.22232 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, DRD1, FABP3, FLT3, IGF1R, MMP2, NR3C1, PPARA, SRC, TRPV1 |
4.11098 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1 |
4.02067 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1 |
3.99136 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SRC |
3.91033 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1 |
3.89114 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1 |
3.88439 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.85342 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, CDC25B, CHRM1, CSNK2A1, F3, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1 |
3.85342 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.84713 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.84713 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, CHRM1, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
3.84713 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1 |
3.84197 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, XDH |
3.83816 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARA, SRC, TRPV1 |
3.81269 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.77159 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1 |
3.73472 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
3.71559 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, ALOX12, DRD1, MET, TRPV1 |
3.68373 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, KDR, NR3C1, SRC, TRPV1 |
3.67402 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HCAR2, HSD11B1, HSD17B1 |
3.6661 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.6661 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, SRC, TRPV1 |
3.64443 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.63973 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, FABP3, FLT3, NR3C1, PPARA, SRC, TRPV1 |
3.57201 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
3.55656 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
3.50566 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, KDR, SRC, TRPV1 |
3.50552 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1 |
3.50192 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
3.46281 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, FUT7, HSD11B1, KDR, MET, MMP2, MMP9, PIM1, PPARA, SRC |
3.42106 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1 |
3.42106 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 |
3.38538 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
3.37851 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.31327 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, AXL, CYP1A1, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, SRC, TRPV1 |
3.30427 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FLT3, NR3C1, SRC, TRPV1 |
3.25564 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, FABP3, KDR, NR3C1, SRC, TRPV1 |
3.20576 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, CYP19A1, CYP1B1, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
3.20576 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
3.16891 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1 |
3.15598 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1 |
3.15304 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, FABP3, FABP4, FLT3, FUT7, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, NR3C1, PIM1, PPARA, PTPN1, SRC, XDH |
3.15253 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1 |
3.15253 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, HCAR2, KDR, SRC, TRPV1 |
3.11849 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
3.0393 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, FABP3, FLT3, HCAR2, PPARA, SRC |
3.0393 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, PTPN1, SRC, TRPV1 |
2.99173 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, F3, FLT3, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
2.98012 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.96994 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, PTPN1, SRC, XDH |
2.96994 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1 |
2.90649 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AXL, CYP1B1, F3, FLT3, KDR, MET, PTPN1, SRC, XDH |
2.90649 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, FLT3, MET, PIM1, SRC |
2.90649 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.90649 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.90649 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.90649 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, AXL, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, FLT3, HSD11B1, KDR, MMP9, PIM1, PPARA, SRC |
2.86523 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, ALOX12, AXL, CA12, CA2, CA7, DRD1, FABP3, FABP4, FLT3, MET, SRC, TRPV1 |
2.86523 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1 |
2.83706 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.82645 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.81361 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, ALOX12, CHRM1, CHRM3, F3, MET, XDH |
2.81361 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.81361 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.80685 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.80685 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.78702 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, AURKB, AXL, CSNK2A1, CYP1B1, F3, FLT3, IGF1R, KDR, MET, MMP9, PTPN1, SRC, XDH |
2.76489 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, AURKB, AXL, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, F3, FABP3, FABP4, FLT3, IGF1R, KDR, MMP12, MMP2, MMP9, NR3C1, PPARA, PTPN1, SRC, TRPV1 |
2.70158 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, AXL, CA2, CA7, CHRM1, CYP19A1, DRD1, HCAR2, MMP12, MMP9, PPARA, PTPN1, SRC, TRPV1 |
2.65474 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F3, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
2.6512 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
2.64284 |
[BP] GO:0033993 |
response to lipid
|
AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, FABP3, FLT3, NR3C1, SRC |
2.61184 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.54228 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.53596 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1 |
2.52702 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.52702 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.49269 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, IGF1R, MMP2, MMP9, NR3C1, SRC, TRPV1 |
2.4744 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.45826 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, AXL, CSNK2A1, CYP1B1, F3, FABP4, FLT3, KDR, MET, MMP12, MMP2, MMP9, PTPN1, SRC, XDH |
2.45744 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1 |
2.45744 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.44721 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3 |
2.44721 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, CDC25B, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.4338 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, CDC25B, CHRM5, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.42334 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.40048 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.39906 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, AXL, CA2, CHRM3, CYP1B1, F3, HCAR2, KDR, MET, MMP12, MMP9, PIM1, SRC, TRPV1 |
2.39661 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, CDC25B, CHRM5, DRD1, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, SRC, XDH |
2.39574 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, DRD1, F3, FABP4, KDR, MET, MMP12, PPARA |
2.36818 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA |
2.36167 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.36167 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.36167 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, CA2, CHRM1, CYP19A1, DRD1, HCAR2, MMP12, SRC, TRPV1 |
2.3497 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
CYP1A1, CYP1B1, DRD1, FLT3, NR3C1, SRC, TRPV1 |
2.34272 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.31808 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC |
2.31579 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
2.3068 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.3068 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.3068 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.3068 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.28909 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.28694 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, FABP3, FABP4, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
2.28021 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, FLT3, HSD11B1, KDR, PPARA, SRC |
2.2557 |
[BP] GO:0003018 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, SRC |
2.20975 |
[BP] GO:0022617 |
extracellular matrix disassembly
|
MMP1, MMP12, MMP2, MMP9 |
2.19973 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.17029 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, HCAR2, MMP12, SRC, TRPV1 |
2.16478 |
[BP] GO:0032963 |
collagen metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.16384 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1 |
2.13701 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4 |
2.13701 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.13701 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.13701 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.13701 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.13701 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ALOX12, AXL, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, F3, HCAR2, KDR, MET, MMP12, MMP9, PIM1, SRC, TRPV1, XDH |
2.13625 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, TRPV1 |
2.10889 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.10889 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.08789 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.07412 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ALOX12, CYP19A1, F3, FABP4, IGF1R, MET, MMP12, MMP2, PPARA, PTPN1, SRC, XDH |
2.07412 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CYP1A1, CYP1B1, DRD1, KDR, SRC |
2.06215 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, FABP3, FABP4, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
2.0471 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.0427 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.02104 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, AURKB, CDC25B, CSNK2A1, DRD1, F3, FLT3, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PPARA, PTPN1, SRC, TRPV1, XDH |
2.01614 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX12, ALOX15, CYP19A1, DRD1, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, SRC, XDH |
2.01461 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.00441 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.00441 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TRPV1 |
3.68373 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, F3, FLT3, IGF1R, KDR, MET, TRPV1 |
3.12385 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, MET, SRC, TRPV1 |
2.90236 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F3, FLT3, FUT7, HCAR2, HSD11B1, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SRC, TRPV1 |
2.54228 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ALOX15, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, F3, FLT3, IGF1R, KDR, MET, SRC, TRPV1 |
2.44721 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, FLT3, IGF1R, KDR, MET, TRPV1 |
2.20975 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.00441 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, XDH |
11.0062 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.3964 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, F3, FLT3, FUT7, HSD11B1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, XDH |
9.62667 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, SRC, TRPV1, XDH |
7.3923 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.53431 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.32947 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, XDH |
6.18387 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TRPV1 |
5.98577 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.86745 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.49161 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
5.23929 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD11B1, HSD17B1, XDH |
4.61904 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 |
4.57652 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, TRPV1, XDH |
4.46276 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
4.22232 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP12, MMP2, MMP9, NR3C1, PPARA, PTPN1 |
4.20694 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.20694 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 |
3.97 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 |
3.84713 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, TRPV1 |
3.77159 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, TRPV1 |
3.77159 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.76233 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.71204 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, TRPV1 |
3.56395 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.53367 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.51485 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.43299 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, SRC |
3.38941 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.31327 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, TRPV1, XDH |
3.19625 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, HSD17B1, IGF1R, NR3C1 |
3.18566 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.18385 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.99339 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.90649 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.86563 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.8609 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, F3, FABP3, FABP4, HSD17B1, NR3C1, PPARA, TRPV1 |
2.81361 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1 |
2.79057 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.62502 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.52702 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.52702 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.52702 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, XDH |
2.40488 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, HSD17B1, SRC, XDH |
2.34272 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.33941 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.3068 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.3068 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.28909 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.25812 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.25275 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.25275 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.20975 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.13701 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.10889 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.07412 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F3, MMP1, MMP12, MMP2, MMP9 |
2.01461 |
[MF] GO:0008081 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
2.01461 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP3A4 |
2.01351 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.00441 |